眼药水市场概况、增长、趋势、分析、研究报告(2022-2030 年)

  • Report Code : TIPRE00011308
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 188
Buy Now

Eye Drops Market Size, Growth, and Share by 2030

Buy Now

眼药水市场规模预计将从 2022 年的 157.9327 亿美元增至 2030 年的 237.8845 亿美元。预计 2022-2030 年期间市场复合年增长率为 5.3%。白内障病例的增加和技术发展可能仍是市场的主要趋势。

眼药水市场分析

据《柳叶刀》报道,白内障的患病率估计会随着年龄的增长而增加,从 55-64 岁时的 3.9% 增加到 80 岁及以上时的 92.6%。儿童白内障是可治愈的儿童失明的最常见原因之一,估计患病率为每 10,000 个活产婴儿中 1 到 6 个。预计这一因素将在 2022 年至 2030 年的预测期内推动眼药水市场的发展。

眼药水市场概况

根据青光眼研究基金会的数据,2020 年全球约有 8000 万人患有青光眼,预计未来几年这一数字将上升,到 2040 年将达到 1.11 亿。最常见的青光眼治疗方法是处方眼药水。有七种眼药水可用于治疗青光眼。这一因素导致了眼药水市场的增长。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

眼药水市场:

眼药水市场
  • Eye Drops Market
    复合年增长率(2022 - 2030 年)
    5.3%
  • 2022 年市场规模
    157.9327 亿美元
  • 2030 年市场规模
    237.8845 亿美元

市场动态

增长动力
  • 白内障病例增多和技术发展
  • 全球青光眼患者数量不断增加
未来趋势
  • 不适用
机会
  • 创新产品发布

关键人物

  • 博士伦
  • 爱尔康
  • 库博视界
  • 雷迪博士实验室
  • NovaBay 制药公司
  • 蔡司视力保健
  • 维萨眼科公司
  • 泰亚制药公司
  • 远见卓识
  • Lumibird 医疗

区域概况

Eye Drops Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Eye Drops Market类型
  • 抗生素
  • 人工泪液
  • 激素
  • 其他的
Eye Drops Market应用
  • 眼部疾病 [干眼症
  • 青光眼
  • 白内障
  • 其他的]
  • 眼部护理
  • 其他的
Eye Drops Market购买方式
  • 非处方药和处方药
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

眼药水市场驱动因素和机遇

印度视障人士数量不断增加,市场前景看好

据《金融快报》报道,印度约有 495 万盲人和 7000 万视力障碍者。这给经济带来了沉重的负担,据估计,失明造成的国民总收入净损失高达 8450 亿印度卢比。

总体而言,眼部疾病和视力障碍极为常见。据世界卫生组织 (WHO) 估计,全球有超过 22 亿人患有某种形式的视力障碍或失明。

因此,导致眼药水市场增长的主要因素是印度失明人数的增加。

创新产品发布

最近,我们观察到市场参与者正在推出新产品,帮助医生持续监测患者的情况。例如,2020 年,FDA 批准了 MiSight 1 日 (CooperVision) 镜片,使其成为标榜可减缓近视进展的日抛型软性隐形眼镜。临床研究发现,与单视 1 日镜片相比,MiSight 1 日镜片使近视进展减少了 59%(以球面等效测量),平均轴向伸长减少了 52%。

眼药水市场报告细分分析

有助于得出眼药水市场分析的关键部分是类型和购买模式。

  • 根据类型,眼药水市场分为抗生素、人工泪液、激素和其他。抗生素部分在 2022 年占据了最大的市场份额。
  • 根据购买方式,眼药水市场分为非处方药和处方药。处方药部分预计在预测期内将出现更高的复合年增长率。这些包括环孢菌素 (Restasis) 和 Lifitegrast (Xiidra)。

眼药水市场份额按地区分析

眼药水市场报告的地理范围主要分为五个区域:北美洲、亚太地区、欧洲、中东和非洲、南美洲和中美洲。

北美占据了眼药水市场的主导地位。美国青光眼病例和近视病例的增加带动了区域市场的增长。据 Bright Focus 称,超过 300 万美国人患有青光眼,其中 270 万人年龄在 40 岁及以上,并受到其最常见的形式开角型青光眼的影响。预计亚太地区将在未来几年以最高的复合年增长率增长。

眼药水市场报告范围

报告属性细节
2022 年市场规模157.9327亿美元
2030 年的市场规模237.8845亿美元
全球复合年增长率(2022 - 2030 年)5.3%
史料2020-2021
预测期2023-2030
涵盖的领域按类型
  • 抗生素
  • 人工泪液
  • 激素
  • 其他的
按应用
  • 眼部疾病 [干眼症
  • 青光眼
  • 白内障
  • 其他的]
  • 眼部护理
  • 其他的
按购买方式
  • 非处方药和处方药
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 博士伦
  • 爱尔康
  • 库博视界
  • 雷迪博士实验室
  • NovaBay 制药公司
  • 蔡司视力保健
  • 维萨眼科公司
  • 泰亚制药公司
  • 远见卓识
  • Lumibird 医疗
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

眼药水市场新闻及最新发展

通过收集一手和二手研究后的定性和定量数据来评估眼药水市场,其中包括重要的公司出版物、协会数据和数据库。以下列出了眼药水市场的一些发展情况:

  • 美国市场领先的医疗保健公司之一鲁宾宣布在美国推出 0.07% 溴芬酸滴眼液。(来源:CNBC TV18,新闻室,2024 年 1 月)
  • Bausch + Lomb 推出了 INFUSE Multifocal 硅水凝胶 (SiHy) 隐形眼镜,用于日常使用,用于老花眼管理,旨在帮助维持眼表稳态,从而最大限度地减少隐形眼镜干燥。(来源:Glance By Eyes On Eyecare,2023 年 6 月)

眼药水市场报告覆盖范围和交付成果

“眼药水市场规模和预测(2020-2030 年)”报告对以下领域进行了详细的市场分析:

  • 眼药水市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 眼药水市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 眼药水市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及眼药水市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the eye drops market in 2022?

North America has dominated the eye drops market in 2022

What are the driving factors impacting the eye drops market?

Rising cases of cataract diseases and technological developments are likely to remain key trends in the market.

What are the future trends of the eye drops market?

Innovative Product launches is one of the future trends that will drive the overall eye drops market during the forecast period 2022-2030

Which are the leading players operating in the eye drops market?

Bausch+Lomb; Alcon; CooperVision; Dr. Reddy’s Laboratories; NovaBay Pharmaceuticals; ZEISS Vision Care; Verséa Ophthalmics; Théa Pharmaceuticals; Visionary Optic; Lumibird Medical are some leading players operating in the eye drops market

What would be the estimated value of the eye drops market by 2030?

The eye drops market size is projected to reach US$ 23,788.45 million by 2030.

What is the expected CAGR of the eye drops market?

The global eye drops market is estimated to register a CAGR of 5.3% during the forecast period 2022-2030

The List of Companies - Eye Drop Market

  1. Akorn Consumer Health
  2. Alcon AG
  3. AbbVie
  4. Bausch + Lomb
  5. Biomedica Pvt Ltd
  6. Pfizer
  7. Prestige Consumer Healthcare
  8. Rohto Pharmaceuticals
  9. Sager Pharma
  10. Similasan Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..